We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




ELISA Reader Features Modern Light Source, Small Footprint

By LabMedica International staff writers
Posted on 09 Oct 2012
Performance features of a new microplate absorbance reader include optimized optics, a modern light source of principally unlimited lifetime, and a multiple-filter capacity that enables a broad range of applications.

The Apollo 11 ELISA Absorbance Reader provided by Berthold Technologies (Bad Wildbad, Germany), a company specializing in bioanalytical instruments for diagnostics and research, is a product of long-time, continuous optimization of ELISA reader technology and in particular introduces its new unlimited life-time LED light source technology. More...
The instrument also has the capacity to install up to six filters, enabling a variety of applications in one system, including DNA quantification, protein quantification, various enzyme activity assays including beta-Galactosidase and for immunoassay/ELISA - alkaline phosphatase and horseradish peroxidase. For extraordinary accuracy and precision (providing dependable measurement repeatability and traceable, comparable results), the Apollo 11 reader has an unusually large dynamic range of 0 to 3.7 OD, sophisticated optics, a robust mechanical design, and an integrated function that performs autocheck and autocalibration of the optics and electronics before every measurement.

An additional valuable feature is the PhotoRead software for showing on a single screen: data, commands, settings, and displays needed during operation. The easy-to-use self-explaining one-view PhotoRead software also allows initiation of measurements within seconds. Microplate shaking can be adjusted from a choice of 4 amplitudes and 4 speeds. Also notable is that the unit’s small footprint size (210 x 281 x 160 mm) saves valuable laboratory space.

Related Links:

Berthold Technologies


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.